We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current EVGN market cap is 8.6M. The company's latest EPS is USD -2.5305 and P/E is -0.52.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.19M | 914k | 1.8M | 1.61M | 2.64M |
| Operating Income | -4.09M | -6.12M | -7.46M | -4.58M | -4.13M |
| Net Income | -3.86M | -5.42M | -7.63M | 427k | -2.59M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.04M | 930k | 5.18M | 5.64M | 8.51M |
| Operating Income | -24.81M | -30.95M | -26.94M | -26.51M | -22.25M |
| Net Income | -23.37M | -27.79M | -26.64M | -23.88M | -16.49M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.78M | 40.97M | 40.11M | 39.86M | 34.3M |
| Total Liabilities | 21.4M | 21.03M | 27.88M | 25.03M | 21.91M |
| Total Equity | 25.38M | 19.94M | 12.24M | 14.84M | 12.4M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 71.92M | 76.3M | 56.13M | 51.1M | 39.86M |
| Total Liabilities | 15.03M | 12.88M | 21.34M | 22.42M | 25.03M |
| Total Equity | 56.88M | 63.42M | 34.79M | 28.69M | 14.84M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.11M | -9.57M | -14.49M | -19.7M | -5.18M |
| Investing | -4.36M | -1.15M | 864k | 9.62M | -2.45M |
| Financing | -367k | -518k | 4.22M | 4.66M | -159k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.51M | -24.72M | -23.68M | -21.58M | -19.7M |
| Investing | 9.42M | -20.57M | 13.27M | -4.54M | 9.62M |
| Financing | 20.37M | 30.28M | 9.34M | 18.15M | 4.66M |
| Market Cap | 8.6M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 1.01 |
| Price to Cash Ratio | 0.56 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 6.51M |
| Average Volume (1 week) | 106.26k |
| Average Volume (1 Month) | 6.15M |
| 52 Week Change | -79.25% |
| 52 Week High | 6.798 |
| 52 Week Low | 0.95 |
| Spread (Intraday) | 0.01 (0.75%) |
| Company Name | Evogene Ltd |
| Address |
13 gad feinstein street, park rehovot rehovot, center 7414002 |
| Website | https://www.evogene.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
